Dilmapimod targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
456.42
Molecular Formula
C23H19F3N4O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Dilmapimod serves as a research tool to assess the inhibition of p38 MAP kinase for therapeutic potentials in chronic obstructive pulmonary disease (COPD) and other inflammatory conditions.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
